Clinical Trial Update: Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

View source ↗

Summary

Clinical trial investigating immune profiles, treatment response, and toxicity markers in skin cancer patients treated with cemiplimab using next-generation flo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Libtayo (cemiplimab)

Snippet

Sponsor: Instituto de Investigación Biomédica de Salamanca | Conditions: Cutaneous Squamous Cell Carcinoma (CSCC) | Status: RECRUITING